139 related articles for article (PubMed ID: 7388771)
1. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
Drago JR; Goldman LB; Gershwin ME
Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma.
Drago JR; Goldman LB
Cancer; 1980 Feb; 45(4):757-63. PubMed ID: 7357493
[TBL] [Abstract][Full Text] [Related]
3. Heterotransplantation of Nb rat prostatic adenocarcinomas into congenitally athymic nude mice.
Drago JR; Gershwin ME
Cancer; 1981 Jan; 47(1):55-9. PubMed ID: 7193077
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
Drago JR
J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
[TBL] [Abstract][Full Text] [Related]
6. Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
Drago JR; Worgul TJ
Invest Urol; 1981 Nov; 19(3):191-3. PubMed ID: 7298290
[TBL] [Abstract][Full Text] [Related]
7. The effect of 5-fluorouracil and adriamycin on heterotransplantation of Noble rat prostatic tumors in congenitally athymic (nude) mice.
Drago JR; Maurer RE; Gershwin ME; Eckels D; Palmer JM
Cancer; 1979 Aug; 44(2):424-30. PubMed ID: 476560
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
Drago JR; Goldman L; Gershwin ME
Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
[TBL] [Abstract][Full Text] [Related]
9. Therapy for Nb rat tumor transplanted in athymic mice.
Drago JR; Goldman LB; Worgul T; Gershwin ME
J Surg Oncol; 1981; 16(3):265-72. PubMed ID: 7218811
[TBL] [Abstract][Full Text] [Related]
10. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
[TBL] [Abstract][Full Text] [Related]
11. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
Drago JR; Worgul T
Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
Block NL; Camuzzi F; Denefrio J; Troner M; Claflin A; Stover B; Politano VA
Oncology; 1977; 34(3):110-3. PubMed ID: 917440
[TBL] [Abstract][Full Text] [Related]
13. The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
Drago JR; Palmer J
J Surg Oncol; 1983 Nov; 24(3):215-7. PubMed ID: 6632910
[TBL] [Abstract][Full Text] [Related]
14. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostatic adenocarcinoma. Chemotherapy of autonomous tumor, 102 Pr, heterotransplanted into congenitally athymic (nude) mice and syngeneic Nb rats.
Drago JR; Maurer RE; Goldman LB; Gershwin ME
Cancer Chemother Pharmacol; 1979; 3(3):167-70. PubMed ID: 118827
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model.
Drago JR; Worgul T; Gershwin ME
J Surg Oncol; 1981; 16(4):353-63. PubMed ID: 7195962
[TBL] [Abstract][Full Text] [Related]
16. Nb rat prostate adenocarcinoma model: evaluation of the subrenal capsular assay system.
Drago JR; Lombard J
J Surg Oncol; 1985 Apr; 28(4):270-2. PubMed ID: 3884903
[TBL] [Abstract][Full Text] [Related]
17. The effects of cyclophosphamide, ketoconazole, aclacinomycin-A, methotrexate, and scheduled methotrexate-5-fluorouracil combination chemotherapy on the transplantable R-3327 prostatic adenocarcinoma in the F1 hybrid male rat.
Smith JB; Ghayad PY; Dhabuwala CB; Drelichman A; Pierce JM
Cancer; 1985 Sep; 56(5):1045-8. PubMed ID: 3860279
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
[TBL] [Abstract][Full Text] [Related]
19. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
Drago JR; Smith J
In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.
Smith JB; Ghayad PY; Dhabuwala CB; Drelichman A; Pierce JM
Urology; 1987 Aug; 30(2):143-6. PubMed ID: 3617298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
